Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Zentalis Pharmaceuticals granted non-qualified stock options to purchase 26,000 shares to a newly hired employee as an employment inducement under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $4.09 per share, equal to the closing price on the grant date, and vest over four years with a 10-year term.
Key figures
- Exercise price
- 4.09
- Options granted
- 26000
- Vesting term years
- 10
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.